Axon Enterprise, Inc $AXON Stock: First Command Advisory Services Inc. Raises Holdings

First Command Advisory Services Inc. grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 10,431.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,793 shares of the biotechnology company’s stock after purchasing an additional 7,719 shares during the quarter. First Command Advisory Services Inc.’s holdings in Axon Enterprise were worth $3,293,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. State Street Corp lifted its position in Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after buying an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. grew its holdings in Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after buying an additional 13,127,348 shares during the period. BlackRock Inc. grew its holdings in Axon Enterprise by 4.3% in the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after buying an additional 345,365 shares during the period. Robeco Institutional Asset Management B.V. grew its holdings in Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock valued at $2,952,943,000 after buying an additional 6,987,098 shares during the period. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Axon Enterprise by 8,432.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after acquiring an additional 3,496,493 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Trending Headlines about Axon Enterprise

Investors following AXON have been watching these headlines:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $315.42 on Thursday. The stock’s 50-day moving average is $426.24 and its 200-day moving average is $470.65. The company has a market cap of $25.68 billion, a price-to-earnings ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. Axon Enterprise, Inc has a 12 month low of $291.45 and a 12 month high of $665.07.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The firm’s revenue for the quarter was up 27.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.17 EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider owned 56,264 shares in the company, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on AXON. Needham & Company LLC decreased their target price on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Northcoast Research upped their price target on shares of Axon Enterprise from $650.00 to $680.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research note on Monday, November 2nd. JPMorgan Chase & Co. cut their price target on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a research note on Friday, November 6th. Finally, Argus lifted their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $612.18.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.